$465M Partnership. 59% Response Rate. $5B Buyout.
Gilead Sciences acquires ADC developer Tubulis for up to $5 billion, turning a 2023 partnership into a full buyout.
Category Exit Signals
One Bought a Podcast. The Other Bought a Lab.
Anthropic dropped $400M on a 9-person biotech AI startup. The same day, OpenAI bought a podcast. That tells you everything.
Eli Lilly Buys Centessa for $6.3 Billion to Own the Orexin Franchise
Lilly didn't just buy a drug — they bought an entire orexin franchise. The $6.3B Centessa deal includes three OX2R agonists across clinical and preclinical stages.
Aurinia Acquires Kezar Life Sciences in Kevin Tang’s Biotech Comeback Play
Kevin Tang tried to buy Kezar once and got rejected. Now he's back — as Aurinia's CEO — and this time he got the deal done.